GraphWear Technologies

Overview

About Us Pioneering needle-freedisease monitoring Science is what we do. We founded GraphWear in 2015 to diagnose and monitor chronic conditions, and to do so without any need to test blood or urine.

Funding and backers

Total raised
$4.2M
1 round on record
Latest round
$4.2M
Series A · Apr 2018 · 8 yr ago
Backers
1
Plug and Play
The money's age
Long since its last round
102 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 17, 2018 Raised a round Series A $4.2M
Funding rounds
RoundDateAmountInvestorsSource
Series A Apr 2018 $4.2M — technical.ly
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Myway Digital HealthVenture round · 14 mo ago · Founded 2017 · 11-50 employees
Digital health solutions for chronic conditions Improving.
Jana CareVenture round $1.4M · 7 mo ago · 51-200 employees
Jana Care offers smartphone-enabled at-home health testing that helps patients and care teams monitor chronic conditions with fast…
What we do. We work with global technology leaders to:.
Citadel AI builds products to test and monitor high-risk AI systems. Our mission is to make the world's AI systems more reliable and…
SymPhysis MedicalVenture round $2.4M · 2 yr ago
SymPhysis Medical specializes in medical technology designed to improve the lives of patients with chronic conditions.
juliVenture round $3.8M · 4 yr ago · 51-200 employees
Juli helps you manage your chronic condition using artificial intelligence. We first learn everything that.

Financials

Total raised
$4.2M
Latest round
Series A
Funding rounds
1
Funding rounds
Round Announced Amount
Series A 2018 $4.2M Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Plug and PlayVia a fund
2741 portfolio companies

News

News YahooFinance 5 years ago
GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor
GraphWear, a company pursuing needle-free approaches to glucose monitoring, has closed a $20.5 million Series B round. This Series B round is a vote of confidence by investors in GraphWear's approach: to monitor key metrics in the body, like glucose, with
Read more
Report
News MedCity News 10 years ago
GraphWear Technologies pilots sweat sensor patch with NFL team
GraphWear is also developing a patch to use sweat to assess glucose levels for diabetes patients.
Read more
Report